Literature DB >> 16219912

Regulation and binding of pregnane X receptor by nuclear receptor corepressor silencing mediator of retinoid and thyroid hormone receptors (SMRT).

David R Johnson1, Chia-Wei Li, Liuh-Yow Chen, Jagadish C Ghosh, J Don Chen.   

Abstract

The pregnane X receptor (PXR) is an orphan nuclear receptor predominantly expressed in liver and intestine. PXR coordinates hepatic responses to prevent liver injury induced by environmental toxins. PXR activates cytochrome P450 3A4 gene expression upon binding to rifampicin (Rif) and clotrimazole (CTZ) by recruiting transcriptional coactivators. It remains unclear whether and how PXR regulates gene expression in the absence of ligand. In this study, we analyzed interactions between PXR and the silencing mediator of retinoid and thyroid hormone receptors (SMRT) and determined the role of SMRT in regulating PXR activity. We show that SMRT interacts with PXR in glutathione S-transferase pull-down, yeast two-hybrid, and mammalian two-hybrid assays. The interaction is mediated through the ligand-binding domain of PXR and the SMRTs' nuclear receptor-interacting domain 2. The PXR-SMRT interaction is sensitive to species-specific ligands, and Rif causes an exchange of the corepressor SMRT with the p160 coactivator known as receptor-associated coactivator 3 (RAC3). Deletion of the PXR's activation function 2 helix enhances SMRT binding and abolishes ligand-dependent dissociation of SMRT. Coexpression of PXR with SMRT results in colocalization at discrete nuclear foci. Finally, transient transfection assays show that overexpression of SMRT inhibits PXR's transactivation of the Cyp3A4 promoter, whereas silencing of SMRT enhances the reporter expression. Taken together, our results suggest that the corepressor SMRT may bind to and regulate the transcriptional activity of PXR.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16219912     DOI: 10.1124/mol.105.013375

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  30 in total

1.  Protein phosphatase 2Cbetal regulates human pregnane X receptor-mediated CYP3A4 gene expression in HepG2 liver carcinoma cells.

Authors:  Satyanarayana R Pondugula; Alexander A Tong; Jing Wu; Jimmy Cui; Taosheng Chen
Journal:  Drug Metab Dispos       Date:  2010-06-10       Impact factor: 3.922

Review 2.  Pregnane xenobiotic receptor in cancer pathogenesis and therapeutic response.

Authors:  Satyanarayana R Pondugula; Sridhar Mani
Journal:  Cancer Lett       Date:  2012-08-29       Impact factor: 8.679

3.  Rifampicin-independent interactions between the pregnane X receptor ligand binding domain and peptide fragments of coactivator and corepressor proteins.

Authors:  Punya Navaratnarajah; Bridgett L Steele; Matthew R Redinbo; Nancy L Thompson
Journal:  Biochemistry       Date:  2011-12-20       Impact factor: 3.162

4.  RBCK1, an E3 ubiquitin ligase, interacts with and ubiquinates the human pregnane X receptor.

Authors:  Ritu Rana; Sherry Coulter; Harriet Kinyamu; Joyce A Goldstein
Journal:  Drug Metab Dispos       Date:  2012-11-15       Impact factor: 3.922

5.  A phosphomimetic mutation at threonine-57 abolishes transactivation activity and alters nuclear localization pattern of human pregnane x receptor.

Authors:  Satyanarayana R Pondugula; Cynthia Brimer-Cline; Jing Wu; Erin G Schuetz; Rakesh K Tyagi; Taosheng Chen
Journal:  Drug Metab Dispos       Date:  2009-01-26       Impact factor: 3.922

6.  Tumor suppressor protein p53 negatively regulates human pregnane X receptor activity.

Authors:  Ayesha Elias; Jing Wu; Taosheng Chen
Journal:  Mol Pharmacol       Date:  2013-03-27       Impact factor: 4.436

7.  Pregnane X Receptor and Cancer: Context-Specificity is Key.

Authors:  Satyanarayana R Pondugula; Petr Pavek; Sridhar Mani
Journal:  Nucl Receptor Res       Date:  2016-06-12

8.  Differential regulation of CYP3A4 promoter activity by a new class of natural product derivatives binding to pregnane X receptor.

Authors:  Monimoy Banerjee; Taosheng Chen
Journal:  Biochem Pharmacol       Date:  2013-08-05       Impact factor: 5.858

Review 9.  Regulation of PXR and CAR by protein-protein interaction and signaling crosstalk.

Authors:  Peter Oladimeji; Hongmei Cui; Chen Zhang; Taosheng Chen
Journal:  Expert Opin Drug Metab Toxicol       Date:  2016-06-23       Impact factor: 4.481

10.  Augmentation of estrogen receptor-mediated transcription by steroid and xenobiotic receptor.

Authors:  Nana Rokutanda; Toshiharu Iwasaki; Hiroki Odawara; Rin Nagaoka; Wataru Miyazaki; Akira Takeshita; Yukio Koibuchi; Jun Horiguchi; Noriaki Shimokawa; Yuichi Iino; Yasuo Morishita; Noriyuki Koibuchi
Journal:  Endocrine       Date:  2008-06       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.